Arkin Bio Ventures has 2 portfolio companies on record at Recent Funding. Its most recent investment on record is Reunion Neuroscience's $133M Series A round in September 2025, alongside Plaisance Capital Management, Palo Santo Fund, Novo Holdings and 3 others. By category, its portfolio leans toward Health and bio (2).

What Arkin Bio Ventures invests in

• Health and bio · 2 · 100%

How Arkin Bio Ventures invests

Share is of the 1 round on Recent Funding that name Arkin Bio Ventures. Rounds with no announced date are left out of the year split, and "round" is a round whose stage is not on file.

Arkin Bio Ventures portfolio companies

• RReunion Neuroscience$133MSeries A · Sep 2025
• CCrossbow Therapeuticsbacker

Most frequent co-investors

• NNovo Holdings1 shared round · last Sep 16, 2025
• MMPM Capital1 shared round · last Sep 16, 2025
• PPlaisance Capital Management1 shared round · last Sep 16, 2025
• PPalo Santo Fund1 shared round · last Sep 16, 2025
• MMitsui Global Investment1 shared round · last Sep 16, 2025
• FFemHealth Ventures1 shared round · last Sep 16, 2025

Similar investors

• CCalm/Storm VC2 companies · 2 deals in 12 mo
• HHuatai Zijin Investment2 companies · 2 deals in 12 mo
• IIIMA Ventures2 companies · 2 deals in 12 mo
• SSound Bioventures2 companies · 2 deals in 12 mo
• TTenmile2 companies · 2 deals in 12 mo
• TThe FSE Group2 companies · 2 deals in 12 mo

Investors whose portfolios on Recent Funding center on the same category (Health and bio).

Portfolio companies are the companies on Recent Funding with a round that lists Arkin Bio Ventures, which is a subset of its real portfolio. API: /api/v1/investors/arkin-bio-ventures (get a free API key). More: the most active VC firms and new venture capital funds.